References
- Abd M, Goyfman M, Chaus A, Dabbous F, Tamura L, Sandfort V, Brown A, & Budoff M. The Correlation of Dyslipidemia with the Extent of Coronary Artery Disease in the Multiethnic Study of Atherosclerosis. Journal of Lipid Research, 2018;1-9.
- Ahirwar R, & Mondal PR. Prevalence of obesity in India: A systematic review. Diabetes and Metabolic Syndrome: Clinical Research and Reviews, 2019;13;318-321. https://doi.org/10.1016/j.dsx.2018.08.032
- Alam S, Alam A, Quamri MA, Sofi G, Khan MQ, & Ansari S. A Randomized single blind controlled clinical trial on safety and efficacy of a Unani formulation (Itrifal-e-Sagheer) in dyslipidemia. Tang [Humanituas Medicine], 2020;10(1);4-10. http://dx.doi.org/10.5667/tang.2020.0008
- Anonymous. Unani Medicine in India- An overview. (New Delhi, India: Central Council for Research in Unani Medicine), pp.25, 2016.
- Bays HE, Toth PP, Kris-etherton PM, Abate N, Aronne LJ, Brown WV, Gonzalez-campoy JM, Jones SR, Kumar R, Forge Rla & Samuel VT. Obesity, adiposity, and dyslipidemia: A consensus statement from the National Lipid Association. Journal of Clinical Lipidology, 2013;7;304-383. https://doi.org/10.1016/j.jacl.2013.04.001
- Berawi KN, Hadi S, Lipoeto NI, Wahid I, & Jamsari. Dyslipidemia Incidents Between General Obesity and Central Obesity of Employees with Obesity at Universitas Lampung. Biomedical and Pharmacology Journal, 2018;11(1);201-207. https://doi.org/10.13005/bpj/1364
- Carr MC, & Brunzell JD. Abdominal obesity and dyslipidemia in the metabolic syndrome: Importance of type 2 diabetes and familial combined hyperlipidemia in coronary artery disease risk. Journal of Clinical Endocrinology and Metabolism, 2004;89(6);2601-2607. https://doi.org/10.1210/jc.2004-0432
- Chang YC & Wu WC. Dyslipidemia and diabetic retinopathy. Review of Diabetic Studies, 2013;10(2-3);121-132. https://doi.org/10.1900/RDS.2013.10.121
- Fodor G. Primary Prevention of CVD : Treating Dyslipidemia. American Family Physician, 2011;83(10); 1207-1208.
- Garg R, Aggarwal S, Kumar R & Sharma G. Association of atherosclerosis with dyslipidemia and co-morbid conditions : A descriptive study. Journal of Natural Science, Biology and Medicine, 2015;6(1);163-168. https://doi.org/10.4103/0976-9668.149117
- Hirano T. Pathophysiology of Diabetic Dyslipidemia. Journal of Atherosclerosis and Thrombosis, 2018;25;771-782. https://doi.org/10.5551/jat.RV17023
- Hoosen M. Temperament- an important principle for health preservation in Tibb an-Nabawi and Unani-Tibb. Bangladesh Journal of Medical Science, 2017;16(4);487-495. https://doi.org/10.3329/bjms.v16i4.33600
- Karthikeyan G, Teo KK, Islam S, McQueen JM, Pais P, Wang X, Sato H, Lang chim choy, Amorn CS & Kazmi K. Lipid Profile, Plasma Apolipoproteins, and Risk of a First Myocardial Infarction Among Asians. Journal of the American College of Cardiology, 2009;53(3);244-253. https://doi.org/10.1016/j.jacc.2008.09.041
- Kawanami D, Matoba K & Utsunomiya K. Dyslipidemia in diabetic nephropathy. Renal Replacement Therapy, 2016;2(16);1-9. https://doi.org/10.1186/s41100-016-0028-0
- Mahalle N, Garg M, Naik S & Kulkarni M. Study of pattern of dyslipidemia and its correlation with cardiovascular risk factors in patients with proven coronary artery disease. Indian Journal of Endocrinology and Metabolism, 2014;18(1);48-55. https://doi.org/10.4103/2230-8210.126532
- Munjal YP. API Textbook of Medicine (9th ed.). (The Association of Physicians of India), 2012
- Otsuka T, Takada H, Nishiyama Y, Kodani E, Saiki Y, Kato K & Kawada T. Dyslipidemia and the Risk of Developing Hypertension in a Working-Age Male Population. Journal of the American Heart Association, 2016;5(3);1-9. https://doi.org/10.1161/JAHA.115.003053
- Paccaud F, Schlüter-Fasmeyer V, Wietlisbach V & Bovet P. Dyslipidemia and abdominal obesity: an assessment in three general populations. Journal of Clinical Epidemiology, 2000;53(4);393-400. https://doi.org/10.1016/S0895-4356(99)00184-5
- Pretis Nde, Amodio A & Frulloni L. Hypertriglyceridemic pancreatitis: Epidemiology, pathophysiology and clinical management. United European Gastroenterology Journal, 2018;6(5);649-655. https://doi.org/10.1177/2050640618755002
- Saeed AA. Anthropometric predictors of dyslipidemia among adults in Saudi Arabia. Epidemiology Biostatistics and Public Health, 2013;10(1);1-11. https://doi.org/10.2427/8733
- Sarkar P, Mahadeva SK, Raghunath H, Nimisha V & Mandela TS. Utility of Anthropometric Indices as a Predictor of Dyslipidemia. Journal of Medical Sciences and Health, 2015;01(03); 10-13. https://doi.org/10.46347/jmsh.2015.v01i03.003
- WHO. The Global Health Observatory. World Health Organisation; World Health Organization, 2011. Available at: https://www.who.int/data/gho/data/themes/themedetails/GHO/body-mass-index-(bmi) [Accessed on 5th December 2020]
- WHO. Global Health Observatory (GHO) data, 2016. Available at: https://www.who.int/gho/ncd/risk_factors/cholesterol_text/en/ [Accessed on 5th December 2020]